Underdosing Is the Quiet Failure of the Peptide Market

Across thousands of samples, the headline most people chase is purity. It photographs well and it fits on a label. But when we line up measured content against label claim, the larger and more consistent problem is quantity.

A vendor can hit ninety nine percent purity and still ship a vial that holds eighty five percent of the stated milligrams. The buyer sees a clean certificate and never learns that one in seven doses simply is not there.

We treat dose accuracy as a first class metric for this reason. Every published result shows the measured fill so the gap between promise and product is visible at a glance.